Biotech · Private company · Irvine, CA, US
Nuravax, Inc.
Track this companyFree. Adds Nuravax, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- DUVAX 200 µgPhase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- DUVAX 400 µgPhase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and TauPHASE1 · RECRUITING · started Sep 25, 2026ClinicalTrials.gov NCT07142278 · fetched Nov 12, 2026
NIH awards2
- Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy VolunteersFiscal year 2026 · $1.3MNIH RePORTER 4R44AG091903-02 · fetched Nov 12, 2026
- Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy VolunteersFiscal year 2025 · $499.8KNIH RePORTER 1R44AG091903-01 · fetched Nov 12, 2026